Breaking News on Global Pharmaceutical Technology & Manufacturing

Top Headlines

Progress seen In addressing US drug shortages, but challenges remain

New US drug shortages this year are running roughly at the same levels as the last two years, and far below the record highs seen earlier this decade, the US FDA told in-Pharmatechnologist.

Fareva buys Merck & Co API plant in France and outlines plan to invest €25m

Fareva has bought an API plant in France from Merck & Co. and outlined plans to turn it into a high-potency actives site.

Cure not kill: Dynamite ingredient can improve cancer treatment says study

Nitroglycerin could make cancer drugs more effective say researchers trying to use the dynamite ingredient to help destroy tumours.

Europe bans drugs tested by GVK; FDA monitors but keeps allowing sales

The US FDA has found no systemic issues affecting the safety or efficacy of generics clinically tested at GVK BioSciences, but says it supports Europe’s ban of around 700 products.

Novo Nordisk to pump $2bn into diabetes network on back of oral GLP-1 milestone

Novo Nordisk could spend up to $2bn (€1.8bn) on two facilities to support its diabetes portfolio, including an oral long-acting GLP-1 analogue set to enter Phase III trials.

Key Industry Events


Access all events listing

Our events, Shows & Conferences...